SRZN Stock Analysis: Buy, Sell, or Hold?
SRZN - Surrozen, Inc. Common
$22.75
-0.06 (-0.26%)
▼
5d:
-1.13%
30d:
-2.65%
90d:
-23.81%
HOLD
MODERATE Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 14, 2026
30d
Get Alerted When SRZN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SRZN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SRZN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SRZN is currently trading at $22.75, which is considered slightly low relative to its 30-day fair value range of $22.22 to $24.88.
Technical Outlook: Technically, SRZN is in a uptrend. Immediate support is located at $20.50, while resistance sits at $27.08.
Market Sentiment: SRZN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $42.50 (+86.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SRZN is in a uptrend. Immediate support is located at $20.50, while resistance sits at $27.08.
Market Sentiment: SRZN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $42.50 (+86.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$22.22 -
$24.88
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 86.3% below Wall St target ($42.50)
Trading Range Analysis
30-Day Trading Range
$22.22 -
$24.88
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$20.50
Resistance Level
$27.08
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.72
Wall Street Target
$42.50
(+86.3%)
Revenue Growth (YoY)
408.6%
Share & Embed Analysis
Last updated: July 14, 2026 2:59 PM ET
Data refreshes hourly during market hours. Next update: 3:59 PM
Data refreshes hourly during market hours. Next update: 3:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRZN showing a specific setup today?
Insider Activity (6 Months)
14
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Tcg Crossover Gp Ii, Llc
BUY
106658 shares
2026-03-24
Tcg Crossover Gp Ii, Llc
BUY
15223 shares
2026-03-23
Tcg Crossover Gp Ii, Llc
BUY
1190 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 65 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1051 | 52 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 50 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$124 | 58 HOLD |
